Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

Figures & data

Table I. Distribution of different HPV types uterine cervical cancer identified by histotype and patient age.

	Squamous carcinomas		Adenocarcinomas		Total
	HPV positive cases (n)	HPV prevalence (%)	HPV positive cases (n)	HPV prevalence (%)	HPV positive cases (n)	HPV prevalence (%)
All	111/119	93.3	32/35	91.4	143/154	92.9
Age(year)
20–39	45/49	91.8	14/14	100	59/63	93.7
40–59	30/31	96.8	13/15	86.7	43/46	93.5
Over 60	36/39	92.3	5/6	83.3	41/45	91.1
HPV type
HR HPV
16	76	63.9	14	40.0	90	58.4
18	12	10.1	17	48.6	29	18.8
31	5	4.2	0	0	5	3.2
33	7	5.9	0	0	7	4.5
35	1	0.8	0	0	1	0.6
39	2	1.7	1	2.9	3	1.9
45	3	2.5	2	5.7	5	3.2
51	2	1.7	0	0	2	1.3
52	3	2.5	0	0	3	1.9
56	4	3.4	0	0	4	2.6
59	2	1.7	0	0	2	1.3
68	1	0.8	0	0	1	0.6
73	2	1.7	0	0	2	1.3
82	1	0.8	0	0	1	0.6
Putative HR types
53	1	0.8	0	0	1	0.6
66	1	0.8	0	0	1	0.6
LR HPV
42	1	0.8	0	0	1	0.6
70	1	0.8	0	0	1	0.6
HPV16 and/or 18	83	69.7	31	88.6	114	74.0
HPV16 + 18	5	4.2	0	0	5	3.2
Multiple HPV types	10	8.4	2	5.7	12	7.8

Table II. Distribution of single and multiple HPV types in uterine cervical cancer identified by histotype.

HPV type	Squamous carcinomas (Number of cases)	Adenocarcinomas (Number of cases)	Total (Number of cases)
16	70	13	83
18	7	16	23
31	5	0	5
33	5	0	5
45	3	1	4
51	2	0	2
56	2	0	2
73	2	0	2
35	1	0	1
39	1	0	1
52	1	0	1
59	1	0	1
68	1	0	1
16+18	4	0	4
16+45	0	1	1
18+39	0	1	1
33+[53]	1	0	1
33 + 59	1	0	1
52+56	1	0	1
16+18 + (70)	1	0	1
16+39+52	1	0	1
56+82+[66]+ (42)	1	0	1

*Note: [] means Putative HR HPV types; ( ) means LR HPV types.